News

Harold Litt named new editor of RSNA's cardiothoracic imaging journal

Litt, a leading name in the fields of radiology and cardiology, has been with the journal since it was first launched in 2019.

Hospital for Special Surgery pediatric MRI

Vigilance needed to ensure safety in pediatric MR imaging, experts warn

The conclusions are based on an analysis of safety data from five leading pediatric hospitals, spanning 2017 to 2022, published in JACR.

President Trump's presidential proclamation Sept. 19 to implement a $100,000 fee for H-1B visa applications had immediate backlash from dozens of medical societies. Groups like the American Medical Association (AMA) and the American College of Cardiology (ACC) said this will cut off the flow of foreign physicians into the U.S. at a time when we cannot graduate enough American physicians to fill positions in a healthcare system that is facing a rapidly growing physician shortage.

Administration quietly lifts hold on immigration applications for radiologists and other docs

This comes after medical societies and immigration attorneys have for months sought exemptions for physicians, given widespread staffing shortages.

RadNet revises financial projections upward after ‘record’ quarter, with revenue up 22%

This comes after RadNet executed several acquisitions so far this year, including buying French AI firm Gleamer for approximately $270 million.

‘Population autopsy’ finds the US with more avoidable deaths than other wealthy countries

The United States appears to be leading all high-income countries in an unfortunate, distinctly undesirable statistical category.

New ultrasound needle yielded more substantial tissue samples

New ultrasound needle could significantly improve tissue yield during biopsies

Vibrating at up to 30,000 times per second, the sonographic device helps tissue to detach more easily without inflicting a large puncture wound to collect an adequate amount of tissue.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Bayer's new imaging agent for cardiac amyloidosis impresses in clinical trial

The REVEAL study has been assessing the sensitivity and specificity of iodine 124 evuzamitide (I 124 evuzamitide), a PET agent capable of visualizing signs of cardiac amyloidosis on imaging.

Florida doctor charged with manslaughter in patient death describes chaotic scene in deposition

NBC News obtained a copy of the November deposition, linked to a civil lawsuit against Thomas Shaknovsky, MD, accused of removing a patient’s liver instead of spleen, killing him. The surgeon, who has lost his license to practice medicine in Florida, has also been criminally charged with second degree manslaughter. He denies any intentional wrongdoing.

Subhasis Chatterjee, MD. FACS, FACC, FCCP, Associate Professor of Surgery, Director Thoracic Surgical ICU and ECMO Program, Texas Heart Institute at CHI Baylor St. Lukes, explains the new 2026 expert consensus on heparin induced thrombocytopenia (HIT) released at the American Association for Thoracic Surgery (AATS) 2026 annual meeting. #AATS #AATS2026 #AATS26

AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.

doctor wrong patient wrong-site surgery medical error malpractice mistake

FDA announces more recalls due to risk of syringe breaking during treatment

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.

How expert guidelines have influenced TAVR vs. SAVR decisions

As popular as TAVR is today, SAVR continues to play a significant role in the management of patients with valvular disease.

Opposition forming against radiologist nominee for surgeon general

“Dr. Saphier would be a catastrophic mistake on messaging and communicating with MAHA at a time where the coalition is very fragile,” one opponent says.

Around the web

Cardiovascular Business